Investment Stage

Focus Areas

About Investor

Klaus Dugi serves as Venture Partner and Chief Medical Officer at NanoDimension in Switzerland, focusing on investments in BioTech, Health & Hospital Services, Health IT, Digital Health, and Therapeutics sectors across Pre-seed, Seed, Series A, and Series B stages with investment ranges of $100K - $5.0M. His professional background includes 18 years in the pharmaceutical industry with Boehringer Ingelheim and Ferring before joining ND Capital in 2021. Dugi's medical and pharmaceutical expertise provides him with unique insights into healthcare innovation and investment opportunities. His dual role as both an investor and Chief Medical Officer allows him to bridge the gap between medical science and venture capital, supporting the development of groundbreaking healthcare technologies.